전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
lvef < 40
lvef < 40%
마지막 업데이트: 2017-04-26
사용 빈도: 2
품질:
경고: 보이지 않는 HTML 형식이 포함되어 있습니다
lvef neupravila
confirmed,
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
lvef 40 % až
lvef 40% to
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
lvef = ejekčná frakcia ľavej komory
lvef = left ventricular ejection fraction
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
v klinických štúdiách mali pacienti východiskovú lvef 50 %.
in clinical studies, patients had a lvef 50% at baseline.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
tento pokles lvef nejavil známky progresie a často sa upravil pri pokračovaní liečby.
these lvef declines do not appear to have been progressive and often improved as treatment continued.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
potvrdený pokles lvef ≥ 15% oproti východiskovej hodnote a pod 50%)
symptomatic chf confirmed lvef drops of ≥ 15% from baseline and below 50%
마지막 업데이트: 2012-04-12
사용 빈도: 2
품질:
na začiatku liečby a potom v pravidelných intervaloch počas liečby sunitinibom sa má zvážiť vyšetrenie lvef.
baseline and periodic evaluations of lvef should also be considered while the patient is receiving sunitinib.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
akákoľvek kardiovaskulárna toxicita 3. alebo 4. stupňa podľa nyha* alebo pretrvávajúci pokles lvef
any grade 3 or 4 nyha* cardiovascular toxicity or persistent lvef** decline
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
oproti tomu u 10 zo 48 jedincov liečených doxorubicínom, ktorí mali kardiálnu toxicitu podľa lvef kritérií, sa prejavili aj znaky a symptómy chf.
in contrast, 10 of 48 doxorubicin subjects who had cardiac toxicity by lvef criteria also developed signs and symptoms of chf.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
nepozoroval sa pokles priemernej ejekčnej frakcie ľavej komory (lvef) oproti východiskovej hodnote kedykoľvek počas liečby.
no decrease from baseline in mean left ventricular ejection fraction (lvef) was observed at any time during treatment.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
ak lvef poklesne percentuálne o viac ako 10 bodov od vstupnej hodnoty a pod 50 %, liečba sa má zastaviť a približne do 3 týždňov sa má vykonať opakované hodnotenie lvef.
if lvef percentage drops ≥ 10 points from baseline and to below 50%, treatment should be suspended and a repeat lvef assessment performed within approximately 3 weeks.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
v klinických štúdiách sa poklesy lvef o ≥ 20% resp. pod dolný limit normy vyskytli u približne 2% pacientov s gist liečených sutentom, u 4% pacientov s mrcc rezistentným na cytokíny, u 2% pacientov v placebovej skupine.
in clinical trials, decreases in lvef of ≥ 20% and below the lower limit of normal occurred in approximately 2% of sutent-treated gist patients, 4% of cytokine-refractory mrcc patients, 2% of placebo-treated patients.
마지막 업데이트: 2012-04-12
사용 빈도: 3
품질: